Cerebral white matter disease

There are 6 papers on cerebral white matter disease in aging research: 6 observational studies in people.

Disease

6 papers study it4 more mention it3 findings

See all 10 papers on cerebral white matter disease

“elevated CXCL9 (Q4 vs. Q1) was associated with greater WMHV”
Chemokines CXCL9 and CCL2 in Relation to Cerebral White Matter Disease, Cognitive Decline, and Dementia: The Northern Manhattan StudyNeurology open access2026doi:10.1212/wn9.0000000000000065
  • Humans6

Upstream

2

CCL2

no changein humans1

1 study
  1. CCL2 was not clearly linked with cerebral white matter disease in humans.

    “CCL2 showed no association with WMHV.”

    Humansbrainn = 1,179

    Chemokines CXCL9 and CCL2 in Relation to Cerebral White Matter Disease, Cognitive Decline, and Dementia: The Northern Manhattan Study

    Neurology open access

More on CCL2

NfL

mediatesin humans1

1 study
  1. NfL is linked with cerebral white matter disease in humans (increased LV mass index) (up to 13%).

    “NFL partially mediated up to 13% of the effect of increased LV mass index on white matter damage.”

    Humansincreased LV mass indexwhite mattern = 142

    Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage

    Stroke

More on NfL

Associations

1

CXCL9

upin humans1

1 study
  1. CXCL9 is associated with cerebral white matter disease in humans (β=0.19, 95%CI 0.04-0.33).

    “elevated CXCL9 (Q4 vs. Q1) was associated with greater WMHV”

    Humansadjusted for socio-demographics, vascular risk factors, kidney function, and APOE ε4 statusbrain12.2±1.3 yearsn = 1,179

    Chemokines CXCL9 and CCL2 in Relation to Cerebral White Matter Disease, Cognitive Decline, and Dementia: The Northern Manhattan Study

    Neurology open access

More on CXCL9

Latest

Dec 2025: 2Jan 2026: 0Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 04 papers in 12 months